Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Predictive Biosciences snaps up OncoDiagnostic Laboratory

This article was originally published in The Gray Sheet

Executive Summary

Acquisition of privately held, CLIA-certified anatomic pathology and molecular diagnostics lab OncoDiagnostic Laboratory for undisclosed terms on Jan. 7 by cancer test maker Predictive Biosciences will facilitate commercialization in 2010 of the latter firm's non-invasive molecular cancer diagnostic assays. The first assay will be a urine biomarker test for bladder cancer, Predictive Biosciences says. Cleveland-based OncoDiagnostic's "subspecialty expertise and national access to hundreds of urology practices [will] favorably position" Lexington, Mass.-based Predictive for launching its bladder cancer test "as well as future diagnostic products," including prostate and breast cancer assays, Predictive Biosciences explains

You may also be interested in...



Latest UK COVID-19 Specification: For Rapidly Manufactured CPAP Systems

Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.

Podcast: Biopharma's Moment To Deliver On Coronavirus And The People's Hope

Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.

Hengrui Quickly Fills Celgene Void Amid Nationalism Surge In China

China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.

Topics

UsernamePublicRestriction

Register

MT028364

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel